Announcements Trials

Browse Landscape

Status

Terminated 2 Unknown 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 4 Gynecologic 2 Genitourinary 2 Dermatologic 2 Thoracic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gastrointestinal 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Capecitabine 88 Cyclophosphamide 87 Trastuzumab 81 Docetaxel 81 Paclitaxel 65 pyrotinib 55 Epirubicin 55 Tamoxifen 53 Letrozole 51 Fulvestrant 48 Vinorelbine 43 Carboplatin 42 Doxorubicin 41 Radiotherapy 33 exemestane 31 Anastrozole 31 Neoadjuvant Therapy 29 palbociclib 27 Drug Therapy 27 Fluorouracil 24 Bevacizumab 24 pertuzumab 23 Cisplatin 23 eribulin 22 130-nm albumin-bound paclitaxel 21 Goserelin 20 Gemcitabine 20 Exercise 20 Chemotherapy, Adjuvant 19 liposomal doxorubicin 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Data Collection × Breast × Clear all

NCT06240195 2024-03-25

BIO-PROSA

Regina Elena Cancer Institute

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡